Schulz Fran has filed 4 Form 4s with the SEC that we hold, for Senti Biosciences Holdings, Inc. (SNTI) (Director) and Edap Tms Sa (FOCL) (Director). Across all of them we count 1 purchase worth $47.5K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($47.5K) and 0 sales ($0). The largest single trade was a purchase of 10,000 shares of Edap Tms Sa worth $47.5K, dated 2026-08-14. The first filing on our record is dated 2024-12-10 and the latest 2026-08-17.
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-14 | P, purchase reported on Form 4 | 10,000 | $47.5K | 2026-08-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2046804) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms
No password to create and no card required. We store your email address and nothing else.